ID   CP2C9_HUMAN             Reviewed;         490 AA.
AC   P11712; P11713; Q16756; Q16872; Q5VX92; Q6IRV8; Q8WW80;
DT   01-OCT-1989, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 3.
DT   10-MAY-2017, entry version 195.
DE   RecName: Full=Cytochrome P450 2C9;
DE            EC=1.14.13.- {ECO:0000305|PubMed:3243766};
DE   AltName: Full=(R)-limonene 6-monooxygenase;
DE            EC=1.14.13.80 {ECO:0000269|PubMed:11950794};
DE   AltName: Full=(S)-limonene 6-monooxygenase;
DE            EC=1.14.13.48 {ECO:0000269|PubMed:11950794};
DE   AltName: Full=(S)-limonene 7-monooxygenase;
DE            EC=1.14.13.49 {ECO:0000269|PubMed:11950794};
DE   AltName: Full=CYPIIC9;
DE   AltName: Full=Cholesterol 25-hydroxylase {ECO:0000303|PubMed:3079764};
DE            EC=1.14.99.38 {ECO:0000269|PubMed:21576599};
DE   AltName: Full=Cytochrome P-450MP;
DE   AltName: Full=Cytochrome P450 MP-4;
DE   AltName: Full=Cytochrome P450 MP-8;
DE   AltName: Full=Cytochrome P450 PB-1;
DE   AltName: Full=S-mephenytoin 4-hydroxylase {ECO:0000303|PubMed:3079764};
GN   Name=CYP2C9; Synonyms=CYP2C10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-144.
RX   PubMed=2827463;
RA   Meehan R.R., Gosden J.R., Rout D., Hastie N.D., Friedberg T.,
RA   Adesnik M., Buckland R., van Heyningen V., Fletcher J.M., Spurr N.K.,
RA   Sweeney J., Wolf C.R.;
RT   "Human cytochrome P-450 PB-1: a multigene family involved in
RT   mephenytoin and steroid oxidations that maps to chromosome 10.";
RL   Am. J. Hum. Genet. 42:26-37(1988).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT CYS-144.
RX   PubMed=3697070; DOI=10.1093/nar/15.23.10053;
RA   Kimura S., Pastewka J., Gelboin H.V., Gonzalez F.J.;
RT   "cDNA and amino acid sequences of two members of the human P450IIC
RT   gene subfamily.";
RL   Nucleic Acids Res. 15:10053-10054(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-144; HIS-150;
RP   ARG-251; GLY-272; LEU-359 AND SER-489.
RG   NIEHS SNPs program;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   CYS-144.
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 4-490 (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=2963808; DOI=10.1093/oxfordjournals.jbchem.a122145;
RA   Yasumori T., Kawano S., Nagata K., Shimada M., Yamazoe Y., Kato R.;
RT   "Nucleotide sequence of a human liver cytochrome P-450 related to the
RT   rat male specific form.";
RL   J. Biochem. 102:1075-1082(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-490 (ISOFORM 1), AND VARIANTS CYS-358
RP   AND ASP-417.
RC   TISSUE=Liver;
RX   PubMed=3032244; DOI=10.1021/bi00378a016;
RA   Umbenhauer D.R., Martin M.V., Lloyd R.S., Guengerich F.P.;
RT   "Cloning and sequence determination of a complementary DNA related to
RT   human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase.";
RL   Biochemistry 26:1094-1099(1987).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-490 (ISOFORM 1), AND VARIANTS CYS-358
RP   AND ASP-417.
RX   PubMed=3196692; DOI=10.1021/bi00418a039;
RA   Ged C., Umbenhauer D.R., Bellew T.M., Bork R.W., Srivastava P.K.,
RA   Shinriki N., Lloyd R.S., Guengerich F.P.;
RT   "Characterization of cDNAs, mRNAs, and proteins related to human liver
RT   microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.";
RL   Biochemistry 27:6929-6940(1988).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 14-490 (ISOFORM 1).
RX   PubMed=1445376;
RA   Ohgiya S., Komori M., Ohi H., Shiramatsu K., Shinriki N., Kamataki T.;
RT   "Six-base deletion occurring in messages of human cytochrome P-450 in
RT   the CYP2C subfamily results in reduction of tolbutamide hydroxylase
RT   activity.";
RL   Biochem. Int. 27:1073-1081(1992).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-29, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL
RP   PROPERTIES, AND CHARACTERIZATION.
RX   PubMed=3079764;
RA   Shimada T., Misono K.S., Guengerich F.P.;
RT   "Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a
RT   prototype of genetic polymorphism in oxidative drug metabolism.
RT   Purification and characterization of two similar forms involved in the
RT   reaction.";
RL   J. Biol. Chem. 261:909-921(1986).
RN   [13]
RP   PROTEIN SEQUENCE OF 1-25, AND CATALYTIC ACTIVITY.
RX   PubMed=3243766;
RA   Komori M., Hashizume T., Ohi H., Miura T., Kitada M., Nagashima K.,
RA   Kamataki T.;
RT   "Cytochrome P-450 in human liver microsomes: high-performance liquid
RT   chromatographic isolation of three forms and their characterization.";
RL   J. Biochem. 104:912-916(1988).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1857342;
RA   Srivastava P.K., Yun C.H., Beaune P.H., Ged C., Guengerich F.P.;
RT   "Separation of human liver microsomal tolbutamide hydroxylase and (S)-
RT   mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.";
RL   Mol. Pharmacol. 40:69-79(1991).
RN   [15]
RP   PROTEIN SEQUENCE OF 1-9; 21-157; 169-249; 264-424; 426-476 AND
RP   484-487.
RX   PubMed=8809086; DOI=10.1006/abbi.1996.0414;
RA   Haining R.L., Hunter A.P., Veronese M.E., Trager W.F., Rettie A.E.;
RT   "Allelic variants of human cytochrome P450 2C9: baculovirus-mediated
RT   expression, purification, structural characterization, substrate
RT   stereoselectivity, and prochiral selectivity of the wild-type and
RT   I359L mutant forms.";
RL   Arch. Biochem. Biophys. 333:447-458(1996).
RN   [16]
RP   PROTEIN SEQUENCE OF 1-20.
RX   PubMed=8215449; DOI=10.1006/abbi.1993.1536;
RA   Sandhu P., Baba T., Guengerich F.P.;
RT   "Expression of modified cytochrome P450 2C10 (2C9) in Escherichia
RT   coli, purification, and reconstitution of catalytic activity.";
RL   Arch. Biochem. Biophys. 306:443-450(1993).
RN   [17]
RP   CATALYTIC ACTIVITY.
RX   PubMed=11950794; DOI=10.1124/dmd.30.5.602;
RA   Miyazawa M., Shindo M., Shimada T.;
RT   "Metabolism of (+)- and (-)-limonenes to respective carveols and
RT   perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.";
RL   Drug Metab. Dispos. 30:602-607(2002).
RN   [18]
RP   CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=21576599; DOI=10.1194/jlr.M014084;
RA   Honda A., Miyazaki T., Ikegami T., Iwamoto J., Maeda T., Hirayama T.,
RA   Saito Y., Teramoto T., Matsuzaki Y.;
RT   "Cholesterol 25-hydroxylation activity of CYP3A.";
RL   J. Lipid Res. 52:1509-1516(2011).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 30-490.
RX   PubMed=12861225; DOI=10.1038/nature01862;
RA   Williams P.A., Cosme J., Ward A., Angove H.C., Matak-Vinkovic D.,
RA   Jhoti H.;
RT   "Crystal structure of human cytochrome P450 2C9 with bound warfarin.";
RL   Nature 424:464-468(2003).
RN   [21]
RP   VARIANTS CYP2C9*2 CYS-144 AND CYP2C9*3 LEU-359.
RX   PubMed=8946475;
RA   Stubbins M.J., Harries L.W., Smith G., Tarbit M.H., Wolf C.R.;
RT   "Genetic analysis of the human cytochrome P450 CYP2C9 locus.";
RL   Pharmacogenetics 6:429-439(1996).
RN   [22]
RP   VARIANTS CYP2C9*2 CYS-144; CYS-358; CYP2C9*3 LEU-359 AND ASP-417.
RX   PubMed=9110362;
RA   Bhasker C.R., Miners J.O., Coulter S., Birkett D.J.;
RT   "Allelic and functional variability of cytochrome P4502C9.";
RL   Pharmacogenetics 7:51-58(1997).
RN   [23]
RP   VARIANT CYP2C9*4 THR-359.
RX   PubMed=10739176; DOI=10.1097/00008571-200002000-00011;
RA   Imai J., Ieiri I., Mamiya K., Miyahara S., Furuumi H., Nanba E.,
RA   Yamane M., Fukumaki Y., Ninomiya H., Tashiro N., Otsubo K.,
RA   Higuchi S.;
RT   "Polymorphism of the cytochrome P450 (CYP) 2C9 gene in Japanese
RT   epileptic patients: genetic analysis of the CYP2C9 locus.";
RL   Pharmacogenetics 10:85-89(2000).
RN   [24]
RP   VARIANT CYP2C9*5 GLU-360.
RX   PubMed=11455026;
RA   Dickmann L.J., Rettie A.E., Kneller M.B., Kim R.B., Wood A.J.,
RA   Stein C.M., Wilkinson G.R., Schwarz U.I.;
RT   "Identification and functional characterization of a new CYP2C9
RT   variant (CYP2C9*5) expressed among African Americans.";
RL   Mol. Pharmacol. 60:382-387(2001).
RN   [25]
RP   VARIANT CYP2C9*11 TRP-335.
RX   PubMed=11926893; DOI=10.1001/jama.287.13.1690;
RA   Higashi M.K., Veenstra D.L., Kondo L.M., Wittkowsky A.K.,
RA   Srinouanprachanh S.L., Farin F.M., Rettie A.E.;
RT   "Association between CYP2C9 genetic variants and anticoagulation-
RT   related outcomes during warfarin therapy.";
RL   JAMA 287:1690-1698(2002).
RN   [26]
RP   VARIANTS CYS-144; HIS-150; ARG-251; TRP-335; LEU-359; GLU-360 AND
RP   PRO-413.
RX   PubMed=15469410; DOI=10.1517/14622416.5.7.895;
RA   Solus J.F., Arietta B.J., Harris J.R., Sexton D.P., Steward J.Q.,
RA   McMunn C., Ihrie P., Mehall J.M., Edwards T.L., Dawson E.P.;
RT   "Genetic variation in eleven phase I drug metabolism genes in an
RT   ethnically diverse population.";
RL   Pharmacogenomics 5:895-931(2004).
RN   [27]
RP   VARIANT LEU-125.
RX   PubMed=21451434; DOI=10.1097/FPC.0b013e328344c340;
RA   Ciccacci C., Falconi M., Paolillo N., Oteri F., Forte V., Novelli G.,
RA   Desideri A., Borgiani P.;
RT   "Characterization of a novel CYP2C9 gene mutation and structural
RT   bioinformatic protein analysis in a warfarin hypersensitive patient.";
RL   Pharmacogenet. Genomics 21:344-346(2011).
RN   [28]
RP   VARIANT HIS-204.
RX   PubMed=23582453; DOI=10.1016/j.thromres.2013.03.019;
RA   Nahar R., Dube D., Parakh R., Deb R., Saxena R., Singh T.P.,
RA   Verma I.C.;
RT   "Implication of novel CYP2C9*57 (p.Asn204His) variant in coumarin
RT   hypersensitivity.";
RL   Thromb. Res. 131:535-539(2013).
RN   [29]
RP   VARIANT HIS-125.
RX   PubMed=24956244; DOI=10.2217/pgs.14.47;
RA   Lee Y.M., Eggen J., Soni V., Drozda K., Nutescu E.A., Cavallari L.H.;
RT   "Warfarin dose requirements in a patient with the CYP2C9*14 allele.";
RL   Pharmacogenomics 15:909-914(2014).
RN   [30]
RP   VARIANT PHE-434, CHARACTERIZATION OF VARIANT PHE-434,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION.
RX   PubMed=25994031; DOI=10.1124/dmd.115.063412;
RA   Dai D.P., Wang S.H., Li C.B., Geng P.W., Cai J., Wang H., Hu G.X.,
RA   Cai J.P.;
RT   "Identification and Functional Assessment of a New CYP2C9 Allelic
RT   Variant CYP2C9*59.";
RL   Drug Metab. Dispos. 43:1246-1249(2015).
CC   -!- FUNCTION: Cytochromes P450 are a group of heme-thiolate
CC       monooxygenases. In liver microsomes, this enzyme is involved in an
CC       NADPH-dependent electron transport pathway. It oxidizes a variety
CC       of structurally unrelated compounds, including steroids, fatty
CC       acids, and xenobiotics (PubMed:25994031). This enzyme contributes
CC       to the wide pharmacokinetics variability of the metabolism of
CC       drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and
CC       losartan (PubMed:25994031). {ECO:0000269|PubMed:25994031}.
CC   -!- CATALYTIC ACTIVITY: (+)-(R)-limonene + NADPH + O(2) = (+)-trans-
CC       carveol + NADP(+) + H(2)O. {ECO:0000269|PubMed:11950794}.
CC   -!- CATALYTIC ACTIVITY: (-)-(S)-limonene + NADPH + O(2) = (-)-trans-
CC       carveol + NADP(+) + H(2)O. {ECO:0000269|PubMed:11950794}.
CC   -!- CATALYTIC ACTIVITY: (-)-(S)-limonene + NADPH + O(2) = (-)-perillyl
CC       alcohol + NADP(+) + H(2)O. {ECO:0000269|PubMed:11950794}.
CC   -!- CATALYTIC ACTIVITY: Cholesterol + AH(2) + O(2) = 25-
CC       hydroxycholesterol + A + H(2)O. {ECO:0000269|PubMed:21576599}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.25 mM for S-mephenytoin {ECO:0000269|PubMed:3079764};
CC         KM=46.24 uM for tolbutamide {ECO:0000269|PubMed:25994031};
CC         KM=4.73 uM for diclofenac {ECO:0000269|PubMed:25994031};
CC         KM=1.58 uM for losartan {ECO:0000269|PubMed:25994031};
CC         Vmax=9.22 pmol/min/pmol enzyme with tolbutamide as substrate
CC         {ECO:0000269|PubMed:25994031};
CC         Vmax=17.16 pmol/min/pmol enzyme with diclofenac as substrate
CC         {ECO:0000269|PubMed:25994031};
CC         Vmax=210.30 pmol/min/pmol enzyme with losartan as substrate
CC         {ECO:0000269|PubMed:25994031};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral
CC       membrane protein. Microsome membrane
CC       {ECO:0000269|PubMed:21576599}; Peripheral membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P11712-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P11712-2; Sequence=VSP_055573, VSP_055574;
CC         Note=No experimental confirmation available.;
CC   -!- INDUCTION: By rifampicin.
CC   -!- SIMILARITY: Belongs to the cytochrome P450 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Cytochrome P450 Allele Nomenclature Committee;
CC       Note=CYP2C9 alleles;
CC       URL="http://www.cypalleles.ki.se/cyp2c9.htm";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/cyp2c9/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY341248; AAP88931.1; -; Genomic_DNA.
DR   EMBL; AY702706; AAT94065.1; -; Genomic_DNA.
DR   EMBL; AK289420; BAF82109.1; -; mRNA.
DR   EMBL; AL359672; CAH71303.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50019.1; -; Genomic_DNA.
DR   EMBL; CH471066; EAW50020.1; -; Genomic_DNA.
DR   EMBL; BC020754; AAH20754.1; -; mRNA.
DR   EMBL; BC070317; AAH70317.1; -; mRNA.
DR   EMBL; BC125054; AAI25055.1; -; mRNA.
DR   EMBL; D00173; BAA00123.1; -; mRNA.
DR   EMBL; M15331; AAA52157.1; -; mRNA.
DR   EMBL; M21939; AAA52158.1; -; mRNA.
DR   EMBL; M21940; AAA52159.1; -; mRNA.
DR   EMBL; S46963; AAB23864.2; ALT_SEQ; mRNA.
DR   CCDS; CCDS7437.1; -. [P11712-1]
DR   PIR; B38462; B38462.
DR   PIR; D28951; D28951.
DR   RefSeq; NP_000762.2; NM_000771.3. [P11712-1]
DR   RefSeq; XP_016871247.1; XM_017015758.1. [P11712-1]
DR   UniGene; Hs.282624; -.
DR   PDB; 1OG2; X-ray; 2.60 A; A/B=30-490.
DR   PDB; 1OG5; X-ray; 2.55 A; A/B=30-490.
DR   PDB; 1R9O; X-ray; 2.00 A; A=18-490.
DR   PDB; 4NZ2; X-ray; 2.45 A; A/B=30-490.
DR   PDB; 5A5I; X-ray; 2.00 A; A=23-489.
DR   PDB; 5A5J; X-ray; 2.90 A; A=23-489.
DR   PDBsum; 1OG2; -.
DR   PDBsum; 1OG5; -.
DR   PDBsum; 1R9O; -.
DR   PDBsum; 4NZ2; -.
DR   PDBsum; 5A5I; -.
DR   PDBsum; 5A5J; -.
DR   ProteinModelPortal; P11712; -.
DR   SMR; P11712; -.
DR   BioGrid; 107937; 14.
DR   IntAct; P11712; 6.
DR   STRING; 9606.ENSP00000260682; -.
DR   BindingDB; P11712; -.
DR   ChEMBL; CHEMBL3397; -.
DR   DrugBank; DB02507; 4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One.
DR   DrugBank; DB06736; Aceclofenac.
DR   DrugBank; DB01418; Acenocoumarol.
DR   DrugBank; DB00316; Acetaminophen.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB06594; Agomelatine.
DR   DrugBank; DB00969; Alosetron.
DR   DrugBank; DB00404; Alprazolam.
DR   DrugBank; DB01424; Aminophenazone.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB00321; Amitriptyline.
DR   DrugBank; DB00381; Amlodipine.
DR   DrugBank; DB00613; Amodiaquine.
DR   DrugBank; DB00701; Amprenavir.
DR   DrugBank; DB01217; Anastrozole.
DR   DrugBank; DB01435; Antipyrine.
DR   DrugBank; DB06605; Apixaban.
DR   DrugBank; DB00673; Aprepitant.
DR   DrugBank; DB04557; Arachidonic Acid.
DR   DrugBank; DB01274; Arformoterol.
DR   DrugBank; DB06413; Armodafinil.
DR   DrugBank; DB06697; Artemether.
DR   DrugBank; DB01072; Atazanavir.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB01117; Atovaquone.
DR   DrugBank; DB00972; Azelastine.
DR   DrugBank; DB00307; Bexarotene.
DR   DrugBank; DB01128; Bicalutamide.
DR   DrugBank; DB00188; Bortezomib.
DR   DrugBank; DB00559; Bosentan.
DR   DrugBank; DB00835; Brompheniramine.
DR   DrugBank; DB00921; Buprenorphine.
DR   DrugBank; DB01156; Bupropion.
DR   DrugBank; DB08875; Cabozantinib.
DR   DrugBank; DB00201; Caffeine.
DR   DrugBank; DB00796; Candesartan.
DR   DrugBank; DB01101; Capecitabine.
DR   DrugBank; DB00564; Carbamazepine.
DR   DrugBank; DB00748; Carbinoxamine.
DR   DrugBank; DB01136; Carvedilol.
DR   DrugBank; DB00482; Celecoxib.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB00446; Chloramphenicol.
DR   DrugBank; DB00672; Chlorpropamide.
DR   DrugBank; DB00169; Cholecalciferol.
DR   DrugBank; DB00501; Cimetidine.
DR   DrugBank; DB00568; Cinnarizine.
DR   DrugBank; DB00604; Cisapride.
DR   DrugBank; DB00515; Cisplatin.
DR   DrugBank; DB04920; Clevidipine.
DR   DrugBank; DB00758; Clopidogrel.
DR   DrugBank; DB00257; Clotrimazole.
DR   DrugBank; DB00363; Clozapine.
DR   DrugBank; DB00907; Cocaine.
DR   DrugBank; DB01394; Colchicine.
DR   DrugBank; DB01176; Cyclizine.
DR   DrugBank; DB00531; Cyclophosphamide.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB06292; Dapagliflozin.
DR   DrugBank; DB00250; Dapsone.
DR   DrugBank; DB00705; Delavirdine.
DR   DrugBank; DB00967; Desloratadine.
DR   DrugBank; DB01234; Dexamethasone.
DR   DrugBank; DB01191; Dexfenfluramine.
DR   DrugBank; DB04856; Dexloxiglumide.
DR   DrugBank; DB00514; Dextromethorphan.
DR   DrugBank; DB00647; Dextropropoxyphene.
DR   DrugBank; DB00829; Diazepam.
DR   DrugBank; DB00586; Diclofenac.
DR   DrugBank; DB01144; Diclofenamide.
DR   DrugBank; DB00266; Dicoumarol.
DR   DrugBank; DB00255; Diethylstilbestrol.
DR   DrugBank; DB00343; Diltiazem.
DR   DrugBank; DB01075; Diphenhydramine.
DR   DrugBank; DB00822; Disulfiram.
DR   DrugBank; DB00757; Dolasetron.
DR   DrugBank; DB00843; Donepezil.
DR   DrugBank; DB00988; Dopamine.
DR   DrugBank; DB00869; Dorzolamide.
DR   DrugBank; DB01142; Doxepin.
DR   DrugBank; DB00470; Dronabinol.
DR   DrugBank; DB00625; Efavirenz.
DR   DrugBank; DB00216; Eletriptan.
DR   DrugBank; DB08899; Enzalutamide.
DR   DrugBank; DB00668; Epinephrine.
DR   DrugBank; DB01240; Epoprostenol.
DR   DrugBank; DB00876; Eprosartan.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB04574; Estrone sulfate.
DR   DrugBank; DB00402; Eszopiclone.
DR   DrugBank; DB00898; Ethanol.
DR   DrugBank; DB00749; Etodolac.
DR   DrugBank; DB01628; Etoricoxib.
DR   DrugBank; DB06414; Etravirine.
DR   DrugBank; DB01023; Felodipine.
DR   DrugBank; DB01039; Fenofibrate.
DR   DrugBank; DB01195; Flecainide.
DR   DrugBank; DB00196; Fluconazole.
DR   DrugBank; DB04841; Flunarizine.
DR   DrugBank; DB01544; Flunitrazepam.
DR   DrugBank; DB00544; Fluorouracil.
DR   DrugBank; DB00472; Fluoxetine.
DR   DrugBank; DB00712; Flurbiprofen.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB00176; Fluvoxamine.
DR   DrugBank; DB00983; Formoterol.
DR   DrugBank; DB01320; Fosphenytoin.
DR   DrugBank; DB06741; Gavestinel.
DR   DrugBank; DB00317; Gefitinib.
DR   DrugBank; DB01241; Gemfibrozil.
DR   DrugBank; DB01381; Ginkgo biloba.
DR   DrugBank; DB01120; Gliclazide.
DR   DrugBank; DB00222; Glimepiride.
DR   DrugBank; DB01067; Glipizide.
DR   DrugBank; DB01016; Glyburide.
DR   DrugBank; DB01018; Guanfacine.
DR   DrugBank; DB00502; Haloperidol.
DR   DrugBank; DB01159; Halothane.
DR   DrugBank; DB03317; Heme C.
DR   DrugBank; DB01355; Hexobarbital.
DR   DrugBank; DB00667; Histamine Phosphate.
DR   DrugBank; DB00062; Human Serum Albumin.
DR   DrugBank; DB00327; Hydromorphone.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB01177; Idarubicin.
DR   DrugBank; DB01181; Ifosfamide.
DR   DrugBank; DB00619; Imatinib.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB01029; Irbesartan.
DR   DrugBank; DB00951; Isoniazid.
DR   DrugBank; DB09570; Ixazomib.
DR   DrugBank; DB01221; Ketamine.
DR   DrugBank; DB06738; Ketobemidone.
DR   DrugBank; DB01026; Ketoconazole.
DR   DrugBank; DB01009; Ketoprofen.
DR   DrugBank; DB00448; Lansoprazole.
DR   DrugBank; DB01097; Leflunomide.
DR   DrugBank; DB11560; Lesinurad.
DR   DrugBank; DB04725; Licofelone.
DR   DrugBank; DB00281; Lidocaine.
DR   DrugBank; DB01601; Lopinavir.
DR   DrugBank; DB00455; Loratadine.
DR   DrugBank; DB06725; Lornoxicam.
DR   DrugBank; DB00678; Losartan.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB09280; Lumacaftor.
DR   DrugBank; DB01283; Lumiracoxib.
DR   DrugBank; DB00603; Medroxyprogesterone acetate.
DR   DrugBank; DB00784; Mefenamic acid.
DR   DrugBank; DB01065; Melatonin.
DR   DrugBank; DB00814; Meloxicam.
DR   DrugBank; DB00532; Mephenytoin.
DR   DrugBank; DB01357; Mestranol.
DR   DrugBank; DB00333; Methadone.
DR   DrugBank; DB00703; Methazolamide.
DR   DrugBank; DB00763; Methimazole.
DR   DrugBank; DB01028; Methoxyflurane.
DR   DrugBank; DB00916; Metronidazole.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00370; Mirtazapine.
DR   DrugBank; DB01171; Moclobemide.
DR   DrugBank; DB00745; Modafinil.
DR   DrugBank; DB00471; Montelukast.
DR   DrugBank; DB00788; Naproxen.
DR   DrugBank; DB00731; Nateglinide.
DR   DrugBank; DB00220; Nelfinavir.
DR   DrugBank; DB09048; Netupitant.
DR   DrugBank; DB00238; Nevirapine.
DR   DrugBank; DB00622; Nicardipine.
DR   DrugBank; DB06803; Niclosamide.
DR   DrugBank; DB00184; Nicotine.
DR   DrugBank; DB01115; Nifedipine.
DR   DrugBank; DB04868; Nilotinib.
DR   DrugBank; DB00665; Nilutamide.
DR   DrugBank; DB06712; Nilvadipine.
DR   DrugBank; DB00540; Nortriptyline.
DR   DrugBank; DB00334; Olanzapine.
DR   DrugBank; DB09080; Olodaterol.
DR   DrugBank; DB00338; Omeprazole.
DR   DrugBank; DB00904; Ondansetron.
DR   DrugBank; DB04938; Ospemifene.
DR   DrugBank; DB00991; Oxaprozin.
DR   DrugBank; DB01229; Paclitaxel.
DR   DrugBank; DB00213; Pantoprazole.
DR   DrugBank; DB00617; Paramethadione.
DR   DrugBank; DB08439; Parecoxib.
DR   DrugBank; DB00715; Paroxetine.
DR   DrugBank; DB00850; Perphenazine.
DR   DrugBank; DB03783; Phenacetin.
DR   DrugBank; DB01174; Phenobarbital.
DR   DrugBank; DB00946; Phenprocoumon.
DR   DrugBank; DB00191; Phentermine.
DR   DrugBank; DB00812; Phenylbutazone.
DR   DrugBank; DB00252; Phenytoin.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB00554; Piroxicam.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB01411; Pranlukast.
DR   DrugBank; DB06209; Prasugrel.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB00794; Primidone.
DR   DrugBank; DB01032; Probenecid.
DR   DrugBank; DB00396; Progesterone.
DR   DrugBank; DB01131; Proguanil.
DR   DrugBank; DB00420; Promazine.
DR   DrugBank; DB01069; Promethazine.
DR   DrugBank; DB01182; Propafenone.
DR   DrugBank; DB00818; Propofol.
DR   DrugBank; DB00205; Pyrimethamine.
DR   DrugBank; DB01589; Quazepam.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00468; Quinine.
DR   DrugBank; DB01129; Rabeprazole.
DR   DrugBank; DB08896; Regorafenib.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB01201; Rifapentine.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB00533; Rofecoxib.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB01698; Rutin.
DR   DrugBank; DB00936; Salicylic acid.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB00418; Secobarbital.
DR   DrugBank; DB01037; Selegiline.
DR   DrugBank; DB01104; Sertraline.
DR   DrugBank; DB00203; Sildenafil.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB06268; Sitaxentan.
DR   DrugBank; DB00398; Sorafenib.
DR   DrugBank; DB06820; Sulconazole.
DR   DrugBank; DB00359; Sulfadiazine.
DR   DrugBank; DB06150; Sulfadimethoxine.
DR   DrugBank; DB00576; Sulfamethizole.
DR   DrugBank; DB01015; Sulfamethoxazole.
DR   DrugBank; DB08798; Sulfamoxole.
DR   DrugBank; DB00259; Sulfanilamide.
DR   DrugBank; DB06729; Sulfaphenazole.
DR   DrugBank; DB00891; Sulfapyridine.
DR   DrugBank; DB01138; Sulfinpyrazone.
DR   DrugBank; DB00263; Sulfisoxazole.
DR   DrugBank; DB00870; Suprofen.
DR   DrugBank; DB00675; Tamoxifen.
DR   DrugBank; DB06204; Tapentadol.
DR   DrugBank; DB01079; Tegaserod.
DR   DrugBank; DB00231; Temazepam.
DR   DrugBank; DB00444; Teniposide.
DR   DrugBank; DB00469; Tenoxicam.
DR   DrugBank; DB00857; Terbinafine.
DR   DrugBank; DB00342; Terfenadine.
DR   DrugBank; DB00624; Testosterone.
DR   DrugBank; DB01041; Thalidomide.
DR   DrugBank; DB00277; Theophylline.
DR   DrugBank; DB01154; Thiamylal.
DR   DrugBank; DB00679; Thioridazine.
DR   DrugBank; DB00208; Ticlopidine.
DR   DrugBank; DB04831; Ticrynafen.
DR   DrugBank; DB01007; Tioconazole.
DR   DrugBank; DB01124; Tolbutamide.
DR   DrugBank; DB00323; Tolcapone.
DR   DrugBank; DB01036; Tolterodine.
DR   DrugBank; DB00214; Torasemide.
DR   DrugBank; DB05109; Trabectedin.
DR   DrugBank; DB00752; Tranylcypromine.
DR   DrugBank; DB00374; Treprostinil.
DR   DrugBank; DB00755; Tretinoin.
DR   DrugBank; DB00897; Triazolam.
DR   DrugBank; DB00347; Trimethadione.
DR   DrugBank; DB00440; Trimethoprim.
DR   DrugBank; DB00726; Trimipramine.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB01361; Troleandomycin.
DR   DrugBank; DB00580; Valdecoxib.
DR   DrugBank; DB00313; Valproic Acid.
DR   DrugBank; DB00177; Valsartan.
DR   DrugBank; DB00285; Venlafaxine.
DR   DrugBank; DB00661; Verapamil.
DR   DrugBank; DB08828; Vismodegib.
DR   DrugBank; DB00582; Voriconazole.
DR   DrugBank; DB09068; Vortioxetine.
DR   DrugBank; DB00682; Warfarin.
DR   DrugBank; DB04898; Ximelagatran.
DR   DrugBank; DB00549; Zafirlukast.
DR   DrugBank; DB00943; Zalcitabine.
DR   DrugBank; DB06737; Zaltoprofen.
DR   DrugBank; DB00495; Zidovudine.
DR   DrugBank; DB00744; Zileuton.
DR   DrugBank; DB00425; Zolpidem.
DR   DrugBank; DB01198; Zopiclone.
DR   GuidetoPHARMACOLOGY; 1326; -.
DR   SwissLipids; SLP:000001203; -.
DR   iPTMnet; P11712; -.
DR   PhosphoSitePlus; P11712; -.
DR   BioMuta; CYP2C9; -.
DR   DMDM; 6686268; -.
DR   EPD; P11712; -.
DR   PaxDb; P11712; -.
DR   PeptideAtlas; P11712; -.
DR   PRIDE; P11712; -.
DR   Ensembl; ENST00000260682; ENSP00000260682; ENSG00000138109. [P11712-1]
DR   GeneID; 1559; -.
DR   KEGG; hsa:1559; -.
DR   CTD; 1559; -.
DR   DisGeNET; 1559; -.
DR   GeneCards; CYP2C9; -.
DR   HGNC; HGNC:2623; CYP2C9.
DR   HPA; CAB016123; -.
DR   HPA; HPA015066; -.
DR   MalaCards; CYP2C9; -.
DR   MIM; 601130; gene.
DR   neXtProt; NX_P11712; -.
DR   OpenTargets; ENSG00000138109; -.
DR   Orphanet; 413681; Oral antidiabetic drugs toxicity or dose selection.
DR   Orphanet; 413674; Vitamin K antagonists toxicity or dose selection.
DR   PharmGKB; PA126; -.
DR   eggNOG; KOG0156; Eukaryota.
DR   eggNOG; COG2124; LUCA.
DR   GeneTree; ENSGT00760000118775; -.
DR   HOGENOM; HOG000036992; -.
DR   HOVERGEN; HBG015789; -.
DR   InParanoid; P11712; -.
DR   KO; K17719; -.
DR   OMA; KHNQPSE; -.
DR   OrthoDB; EOG091G0BT8; -.
DR   PhylomeDB; P11712; -.
DR   TreeFam; TF352043; -.
DR   BRENDA; 1.14.99.38; 2681.
DR   Reactome; R-HSA-211981; Xenobiotics.
DR   Reactome; R-HSA-211999; CYP2E1 reactions.
DR   Reactome; R-HSA-2142670; Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET).
DR   Reactome; R-HSA-2142816; Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE).
DR   SABIO-RK; P11712; -.
DR   SIGNOR; P11712; -.
DR   ChiTaRS; CYP2C9; human.
DR   EvolutionaryTrace; P11712; -.
DR   GeneWiki; CYP2C9; -.
DR   GenomeRNAi; 1559; -.
DR   PRO; PR:P11712; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000138109; -.
DR   CleanEx; HS_CYP2C9; -.
DR   ExpressionAtlas; P11712; baseline and differential.
DR   Genevisible; P11712; HS.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0031090; C:organelle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0052741; F:(R)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0018675; F:(S)-limonene 6-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0018676; F:(S)-limonene 7-monooxygenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008392; F:arachidonic acid epoxygenase activity; IBA:GO_Central.
DR   GO; GO:0034875; F:caffeine oxidase activity; IDA:BHF-UCL.
DR   GO; GO:0001567; F:cholesterol 25-hydroxylase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0005506; F:iron ion binding; IEA:InterPro.
DR   GO; GO:0004497; F:monooxygenase activity; IDA:BHF-UCL.
DR   GO; GO:0016491; F:oxidoreductase activity; IDA:BHF-UCL.
DR   GO; GO:0019825; F:oxygen binding; TAS:Reactome.
DR   GO; GO:0008395; F:steroid hydroxylase activity; IMP:BHF-UCL.
DR   GO; GO:0043603; P:cellular amide metabolic process; IDA:BHF-UCL.
DR   GO; GO:0042737; P:drug catabolic process; IMP:BHF-UCL.
DR   GO; GO:0017144; P:drug metabolic process; IDA:BHF-UCL.
DR   GO; GO:0019373; P:epoxygenase P450 pathway; IBA:GO_Central.
DR   GO; GO:0042738; P:exogenous drug catabolic process; IDA:BHF-UCL.
DR   GO; GO:0032787; P:monocarboxylic acid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0016098; P:monoterpenoid metabolic process; IDA:BHF-UCL.
DR   GO; GO:0097267; P:omega-hydroxylase P450 pathway; TAS:Reactome.
DR   GO; GO:0055114; P:oxidation-reduction process; IDA:BHF-UCL.
DR   GO; GO:0070989; P:oxidative demethylation; IDA:BHF-UCL.
DR   GO; GO:0008202; P:steroid metabolic process; IMP:BHF-UCL.
DR   GO; GO:0019627; P:urea metabolic process; IDA:BHF-UCL.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   InterPro; IPR001128; Cyt_P450.
DR   InterPro; IPR017972; Cyt_P450_CS.
DR   InterPro; IPR002401; Cyt_P450_E_grp-I.
DR   Pfam; PF00067; p450; 1.
DR   PRINTS; PR00463; EP450I.
DR   PRINTS; PR00385; P450.
DR   SUPFAM; SSF48264; SSF48264; 1.
DR   PROSITE; PS00086; CYTOCHROME_P450; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Endoplasmic reticulum; Heme; Iron;
KW   Lipid metabolism; Membrane; Metal-binding; Microsome; Monooxygenase;
KW   NADP; Oxidoreductase; Polymorphism; Reference proteome;
KW   Steroid metabolism; Sterol metabolism.
FT   CHAIN         1    490       Cytochrome P450 2C9.
FT                                /FTId=PRO_0000051700.
FT   METAL       435    435       Iron (heme axial ligand).
FT   VAR_SEQ     161    162       AS -> GG (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055573.
FT   VAR_SEQ     163    490       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_055574.
FT   VARIANT      19     19       L -> I (in allele CYP2C9*7;
FT                                dbSNP:rs67807361).
FT                                /FTId=VAR_018862.
FT   VARIANT     125    125       R -> H (in allele CYP2C9*35;
FT                                dbSNP:rs72558189).
FT                                {ECO:0000269|PubMed:24956244}.
FT                                /FTId=VAR_075286.
FT   VARIANT     125    125       R -> L (in allele CYP2C9*14).
FT                                {ECO:0000269|PubMed:21451434}.
FT                                /FTId=VAR_075287.
FT   VARIANT     144    144       R -> C (in allele CYP2C9*2;
FT                                dbSNP:rs1799853).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:2827463,
FT                                ECO:0000269|PubMed:3697070,
FT                                ECO:0000269|PubMed:8946475,
FT                                ECO:0000269|PubMed:9110362,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_008343.
FT   VARIANT     150    150       R -> H (in allele CYP2C9*8;
FT                                dbSNP:rs7900194).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018863.
FT   VARIANT     204    204       N -> H (in allele CYP2C9*57).
FT                                {ECO:0000269|PubMed:23582453}.
FT                                /FTId=VAR_075288.
FT   VARIANT     251    251       H -> R (in allele CYP2C9*9;
FT                                dbSNP:rs2256871).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018864.
FT   VARIANT     272    272       E -> G (in allele CYP2C9*10;
FT                                dbSNP:rs9332130). {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018865.
FT   VARIANT     335    335       R -> W (in allele CYP2C9*11;
FT                                dbSNP:rs28371685).
FT                                {ECO:0000269|PubMed:11926893,
FT                                ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_018866.
FT   VARIANT     358    358       Y -> C (in dbSNP:rs1057909).
FT                                {ECO:0000269|PubMed:3032244,
FT                                ECO:0000269|PubMed:3196692,
FT                                ECO:0000269|PubMed:9110362}.
FT                                /FTId=VAR_008344.
FT   VARIANT     359    359       I -> L (in allele CYP2C9*3; responsible
FT                                for the tolbutamide poor metabolizer
FT                                phenotype; dbSNP:rs1057910).
FT                                {ECO:0000269|PubMed:15469410,
FT                                ECO:0000269|PubMed:8946475,
FT                                ECO:0000269|PubMed:9110362,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_008345.
FT   VARIANT     359    359       I -> T (in allele CYP2C9*4;
FT                                dbSNP:rs56165452).
FT                                {ECO:0000269|PubMed:10739176}.
FT                                /FTId=VAR_013515.
FT   VARIANT     360    360       D -> E (in allele CYP2C9*5; increases the
FT                                K(m) value for substrates tested;
FT                                dbSNP:rs28371686).
FT                                {ECO:0000269|PubMed:11455026,
FT                                ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_013516.
FT   VARIANT     413    413       L -> P (in dbSNP:rs28371687).
FT                                {ECO:0000269|PubMed:15469410}.
FT                                /FTId=VAR_024717.
FT   VARIANT     417    417       G -> D. {ECO:0000269|PubMed:3032244,
FT                                ECO:0000269|PubMed:3196692,
FT                                ECO:0000269|PubMed:9110362}.
FT                                /FTId=VAR_008346.
FT   VARIANT     434    434       I -> F (in allele CYP2C9*59; produces
FT                                warfarin hypersensitivity; increases
FT                                affinity but highly decreases enzymatic
FT                                acitivty for tolbutamide; no effect on
FT                                affinity but decreases enzymatic activity
FT                                for diclofenac; decreases affinity and
FT                                highly decreases enzymatic activity for
FT                                losartan). {ECO:0000269|PubMed:25994031}.
FT                                /FTId=VAR_075289.
FT   VARIANT     489    489       P -> S (in allele CYP2C9*12;
FT                                dbSNP:rs9332239). {ECO:0000269|Ref.3}.
FT                                /FTId=VAR_018867.
FT   CONFLICT      4      4       L -> I (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT      6      6       V -> S (in Ref. 2; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT     14     14       L -> M (in Ref. 11; AAB23864).
FT                                {ECO:0000305}.
FT   CONFLICT    175    175       C -> Y (in Ref. 1; no nucleotide entry).
FT                                {ECO:0000305}.
FT   CONFLICT    239    239       F -> L (in Ref. 1; no nucleotide entry).
FT                                {ECO:0000305}.
FT   STRAND       33     35       {ECO:0000244|PDB:1R9O}.
FT   TURN         37     39       {ECO:0000244|PDB:4NZ2}.
FT   HELIX        42     45       {ECO:0000244|PDB:4NZ2}.
FT   HELIX        47     61       {ECO:0000244|PDB:1R9O}.
FT   STRAND       63     71       {ECO:0000244|PDB:1R9O}.
FT   STRAND       73     77       {ECO:0000244|PDB:1R9O}.
FT   HELIX        80     87       {ECO:0000244|PDB:1R9O}.
FT   TURN         88     94       {ECO:0000244|PDB:1R9O}.
FT   STRAND       95     97       {ECO:0000244|PDB:5A5J}.
FT   TURN        105    107       {ECO:0000244|PDB:1R9O}.
FT   STRAND      111    114       {ECO:0000244|PDB:5A5I}.
FT   HELIX       117    131       {ECO:0000244|PDB:1R9O}.
FT   STRAND      134    136       {ECO:0000244|PDB:1R9O}.
FT   HELIX       141    157       {ECO:0000244|PDB:1R9O}.
FT   TURN        158    161       {ECO:0000244|PDB:1R9O}.
FT   HELIX       167    183       {ECO:0000244|PDB:1R9O}.
FT   HELIX       192    208       {ECO:0000244|PDB:1R9O}.
FT   HELIX       211    213       {ECO:0000244|PDB:4NZ2}.
FT   HELIX       214    218       {ECO:0000244|PDB:4NZ2}.
FT   HELIX       222    225       {ECO:0000244|PDB:4NZ2}.
FT   TURN        227    229       {ECO:0000244|PDB:5A5J}.
FT   HELIX       230    253       {ECO:0000244|PDB:1R9O}.
FT   HELIX       263    274       {ECO:0000244|PDB:1R9O}.
FT   STRAND      275    277       {ECO:0000244|PDB:4NZ2}.
FT   HELIX       284    315       {ECO:0000244|PDB:1R9O}.
FT   HELIX       317    330       {ECO:0000244|PDB:1R9O}.
FT   STRAND      333    335       {ECO:0000244|PDB:1R9O}.
FT   HELIX       339    344       {ECO:0000244|PDB:1R9O}.
FT   HELIX       346    359       {ECO:0000244|PDB:1R9O}.
FT   STRAND      374    376       {ECO:0000244|PDB:1R9O}.
FT   STRAND      379    381       {ECO:0000244|PDB:1R9O}.
FT   STRAND      386    389       {ECO:0000244|PDB:1R9O}.
FT   HELIX       392    395       {ECO:0000244|PDB:1R9O}.
FT   TURN        398    400       {ECO:0000244|PDB:1R9O}.
FT   STRAND      401    403       {ECO:0000244|PDB:1R9O}.
FT   HELIX       409    412       {ECO:0000244|PDB:1R9O}.
FT   STRAND      415    417       {ECO:0000244|PDB:1OG5}.
FT   HELIX       431    433       {ECO:0000244|PDB:1R9O}.
FT   HELIX       438    455       {ECO:0000244|PDB:1R9O}.
FT   STRAND      456    462       {ECO:0000244|PDB:1R9O}.
FT   HELIX       464    466       {ECO:0000244|PDB:1R9O}.
FT   STRAND      475    477       {ECO:0000244|PDB:1R9O}.
FT   STRAND      485    489       {ECO:0000244|PDB:1R9O}.
SQ   SEQUENCE   490 AA;  55628 MW;  4FDFC395303A4E3E CRC64;
     MDSLVVLVLC LSCLLLLSLW RQSSGRGKLP PGPTPLPVIG NILQIGIKDI SKSLTNLSKV
     YGPVFTLYFG LKPIVVLHGY EAVKEALIDL GEEFSGRGIF PLAERANRGF GIVFSNGKKW
     KEIRRFSLMT LRNFGMGKRS IEDRVQEEAR CLVEELRKTK ASPCDPTFIL GCAPCNVICS
     IIFHKRFDYK DQQFLNLMEK LNENIKILSS PWIQICNNFS PIIDYFPGTH NKLLKNVAFM
     KSYILEKVKE HQESMDMNNP QDFIDCFLMK MEKEKHNQPS EFTIESLENT AVDLFGAGTE
     TTSTTLRYAL LLLLKHPEVT AKVQEEIERV IGRNRSPCMQ DRSHMPYTDA VVHEVQRYID
     LLPTSLPHAV TCDIKFRNYL IPKGTTILIS LTSVLHDNKE FPNPEMFDPH HFLDEGGNFK
     KSKYFMPFSA GKRICVGEAL AGMELFLFLT SILQNFNLKS LVDPKNLDTT PVVNGFASVP
     PFYQLCFIPV
//
